Skip to Main Content

Filter:

Editors Choice

1 Results

Original Article Non–Small Cell Lung Cancer
Open Archive
Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC
Journal of Thoracic Oncology
Vol. 13Issue 9p1363–1372Published online: May 23, 2018
- Scott Gettinger
- Matthew D. Hellmann
- Laura Q.M. Chow
- Hossein Borghaei
- Scott Antonia
- Julie R. Brahmer
- and others
Cited in Scopus: 123
This phase I study evaluated nivolumab combined with erlotinib in patients with advanced EGFR-mutant NSCLC.